pubmed-article:19506468 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0225326 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0035222 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0242606 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0032539 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0425245 | lld:lifeskim |
pubmed-article:19506468 | lifeskim:mentions | umls-concept:C0019063 | lld:lifeskim |
pubmed-article:19506468 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:19506468 | pubmed:dateCreated | 2009-7-7 | lld:pubmed |
pubmed-article:19506468 | pubmed:abstractText | Acute respiratory distress syndrome (ARDS) is characterized by diffuse inflammation in the lung and resultant permeability edema. Polymyxin B-immobilized fiber (PMX-F) hemoperfusion is effective for sepsis-induced ARDS. High mobility group box-1 protein (HMGB1) is newly recognized as a proinflammatory cytokine. The aim of the study was to determine whether blood HMGB1 levels are increased in patients with ARDS and whether PMX-F treatment affects these levels. Subjects were 20 sepsis-induced patients with ARDS treated by PMX-F column and 20 age-matched healthy volunteers. Polymyxin B-immobilized fiber treatment was carried out twice at a rate of 100 ml/min for 2 hours. Systolic and diastolic blood pressures, the PaO2/FiO2 (PF) ratio and endotoxin, HMGB1, and urinary 8-hydroxy-2'-deoxyguanosine (OHdG) levels were measured before and after PMX-F treatment. Blood endotoxin levels, blood HMGB1 levels, and urinary 8-OHdG levels were significantly higher in patients with ARDS than in healthy volunteers. Systolic and diastolic blood pressures and the PF ratio increased significantly after PMX-F treatments. Polymyxin B-immobilized fiber treatment reduced blood endotoxin, blood HMGB1, and urinary 8-OHdG levels significantly. These data suggest that HMGB1 and oxidative stress play a role in the pathogenesis of ARDS and that PMX-F treatment may ameliorate increased blood HMGB1 and urinary 8-OHdG levels in patients with ARDS. | lld:pubmed |
pubmed-article:19506468 | pubmed:language | eng | lld:pubmed |
pubmed-article:19506468 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19506468 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19506468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19506468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19506468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19506468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19506468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19506468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19506468 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19506468 | pubmed:issn | 1538-943X | lld:pubmed |
pubmed-article:19506468 | pubmed:author | pubmed-author:NakamuraTsuka... | lld:pubmed |
pubmed-article:19506468 | pubmed:author | pubmed-author:KoideHikaruH | lld:pubmed |
pubmed-article:19506468 | pubmed:author | pubmed-author:UedaYoshihiko... | lld:pubmed |
pubmed-article:19506468 | pubmed:author | pubmed-author:SatoEiichiE | lld:pubmed |
pubmed-article:19506468 | pubmed:author | pubmed-author:YamadaShingoS | lld:pubmed |
pubmed-article:19506468 | pubmed:author | pubmed-author:KawagoeYasuhi... | lld:pubmed |
pubmed-article:19506468 | pubmed:author | pubmed-author:FujiwaraNobuh... | lld:pubmed |
pubmed-article:19506468 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19506468 | pubmed:volume | 55 | lld:pubmed |
pubmed-article:19506468 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19506468 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19506468 | pubmed:pagination | 395-9 | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:meshHeading | pubmed-meshheading:19506468... | lld:pubmed |
pubmed-article:19506468 | pubmed:articleTitle | Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome. | lld:pubmed |
pubmed-article:19506468 | pubmed:affiliation | Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan. | lld:pubmed |
pubmed-article:19506468 | pubmed:publicationType | Journal Article | lld:pubmed |